U.S. reaches deal for at-home COVID-19 tests that produce results in 15 minutes

The United States has reached a $230 million deal with the company behind a rapid COVID-19 test that can produce results at home in about 15 minutes, President Biden's administration announced Monday.
Andy Slavitt, White House COVID-19 response adviser, said the Department of Defense and the Department of Health and Human Services have awarded $230 million to Ellume, the company that manufactures the first over-the-counter, fully at-home COVID-19 test to be authorized by the FDA, so they can "scale the manufacturing base and capacity" of the test, per The Wall Street Journal.
"Thanks to this contract, they'll be able to scale their production to manufacture more than 19 million test kits per month by the end of this year, 8.5 million of which are guaranteed to the U.S. government," Slavitt said.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Slavitt also said the company was set to ship 100,000 test kits per month to the U.S. from February through July.
The FDA authorized the Ellume COVID-19 Home Test for emergency use in December, with then-FDA Commissioner Stephen Hahn saying this would allow it to be "sold in places like drug stores, where a patient can buy it, swab their nose, run the test and find out their results" at home. The company said it was planning to sell the tests for $30 or less.
Slavitt added on Monday, "The ability to quickly test, to contact trace and quarantine, is a linchpin of our national strategy and will be a vital part of containing the virus and stopping community spread."
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brendan worked as a culture writer at The Week from 2018 to 2023, covering the entertainment industry, including film reviews, television recaps, awards season, the box office, major movie franchises and Hollywood gossip. He has written about film and television for outlets including Bloody Disgusting, Showbiz Cheat Sheet, Heavy and The Celebrity Cafe.
-
Gavin Newsom's podcast debut is not going over well with some liberals
IN THE SPOTLIGHT The first episode of the California Governor and potential presidential candidate's 'This is Gavin Newsom' featured cozy conversation with far-right operative Charlie Kirk and a surprisingly conservative stance on transgender athletes
By Rafi Schwartz, The Week US Published
-
'Extremists still find plenty of digital spaces'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
South Carolina to execute prisoner by firing squad
speed read Death row inmate Brad Sigmon prefers the squad over the electric chair or lethal injection, his lawyer said
By Peter Weber, The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
California declares bird flu emergency
Speed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
By Rafi Schwartz, The Week US Published